Thc Biomed Intl Stock Analysis
| THCBF Stock | USD 0 0.00 0.00% |
THC Biomed Intl is undervalued with Real Value of 0.00397 and Hype Value of 7.57E-4. The main objective of THC Biomed pink sheet analysis is to determine its intrinsic value, which is an estimate of what THC Biomed Intl is worth, separate from its market price. There are two main types of THC Biomed's stock analysis: fundamental analysis and technical analysis.
The THC Biomed pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and THC Biomed's ongoing operational relationships across important fundamental and technical indicators.
THC |
THC Pink Sheet Analysis Notes
About 29.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.73. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. THC Biomed Intl recorded a loss per share of 0.02. The entity had not issued any dividends in recent years. THC Biomed Intl Ltd. produces and sells medical and recreational cannabis in Canada. THC Biomed Intl Ltd. was founded in 2012 and is headquartered in Kelowna, Canada. Thc Biomed is traded on OTC Exchange in the United States.The quote for THC Biomed Intl is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about THC Biomed Intl learn more at https://thcbiomed.com.THC Biomed Intl Investment Alerts
| THC Biomed Intl is way too risky over 90 days horizon | |
| THC Biomed Intl has some characteristics of a very speculative penny stock | |
| THC Biomed Intl appears to be risky and price may revert if volatility continues | |
| THC Biomed Intl has accumulated 858.43 K in total debt with debt to equity ratio (D/E) of 0.56, which is about average as compared to similar companies. THC Biomed Intl has a current ratio of 0.91, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist THC Biomed until it has trouble settling it off, either with new capital or with free cash flow. So, THC Biomed's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like THC Biomed Intl sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for THC to invest in growth at high rates of return. When we think about THC Biomed's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the revenue of 3.34 M. Net Loss for the year was (3.07 M) with loss before overhead, payroll, taxes, and interest of (1.03 M). | |
| THC Biomed Intl has accumulated about 1.16 M in cash with (1.86 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 29.0% of THC Biomed outstanding shares are owned by corporate insiders |
THC Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 8.59 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate THC Biomed's market, we take the total number of its shares issued and multiply it by THC Biomed's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.THC Profitablity
The company has Profit Margin (PM) of (1.56) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.83) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.83.Technical Drivers
As of the 23rd of November, THC Biomed owns the risk adjusted performance of 0.1147, and Downside Deviation of 59.66. Compared to fundamental indicators, the technical analysis model makes it possible for you to check helpful technical drivers of THC Biomed Intl, as well as the relationship between them. Please validate THC Biomed Intl standard deviation, value at risk, kurtosis, as well as the relationship between the jensen alpha and semi variance to decide if THC Biomed Intl is priced fairly, providing market reflects its prevailing price of 0.001 per share. As THC Biomed Intl appears to be a penny stock we also recommend to double-check its total risk alpha numbers.THC Biomed Intl Price Movement Analysis
The output start index for this execution was two with a total number of output elements of fifty-nine. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. THC Biomed middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for THC Biomed Intl. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
THC Biomed Predictive Daily Indicators
THC Biomed intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of THC Biomed pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 0.001 | |||
| Day Typical Price | 0.001 | |||
| Relative Strength Index | 9.0E-4 |
THC Biomed Forecast Models
THC Biomed's time-series forecasting models are one of many THC Biomed's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary THC Biomed's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About THC Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how THC Biomed prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling THC shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as THC Biomed. By using and applying THC Pink Sheet analysis, traders can create a robust methodology for identifying THC entry and exit points for their positions.
THC Biomed Intl Ltd. produces and sells medical and recreational cannabis in Canada. THC Biomed Intl Ltd. was founded in 2012 and is headquartered in Kelowna, Canada. Thc Biomed is traded on OTC Exchange in the United States.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding THC Biomed to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Sectors Now
SectorsList of equity sectors categorizing publicly traded companies based on their primary business activities |
| All Next | Launch Module |
Complementary Tools for THC Pink Sheet analysis
When running THC Biomed's price analysis, check to measure THC Biomed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy THC Biomed is operating at the current time. Most of THC Biomed's value examination focuses on studying past and present price action to predict the probability of THC Biomed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move THC Biomed's price. Additionally, you may evaluate how the addition of THC Biomed to your portfolios can decrease your overall portfolio volatility.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |